β-Cyclodextrin nanosponges for enhanced anti-melanoma potential of silymarin with functions of anti-oxidant, anti-inflammatory and anti-tyrosinase

Ciążyńska, 2021, Ultraviolet radiation and chronic inflammation—molecules and mechanisms involved in skin carcinogenesis: a narrative review, Life, 11, 326, 10.3390/life11040326 Wu, 2018, Sesamol inhibited melanogenesis by regulating melanin-related signal transduction in B16F10 cells, Int. J. Mol. Sci., 19, 1108, 10.3390/ijms19041108 Neganova, 2021, Therapeutic influence on important targets associated with chronic inflammation and oxidative stress in cancer treatment, Cancers, 13, 6062, 10.3390/cancers13236062 S.H. Hashemi-Shahri, A. Golshan, S.A. Mohajeri, J. Baharara, E. Amini, F. Salek, A. Sahebkar, Z. Tayarani-Najaran, ROS-scavenging and anti-tyrosinase properties of crocetin on B16F10 murine melanoma cells, Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 18 (2018) 1064–1069. Capanema, 2018, Bioengineered carboxymethyl cellulose-doxorubicin prodrug hydrogels for topical chemotherapy of melanoma skin cancer, Carbohydr. Polym., 195, 401, 10.1016/j.carbpol.2018.04.105 Barjasteh, 2022, Green synthesis of PEG-coated MIL-100 (Fe) for controlled release of dacarbazine and its anticancer potential against human melanoma cells, Int. J. Pharm., 618, 10.1016/j.ijpharm.2022.121647 Bayrakçeken Güven, 2022, Food plant with antioxidant, tyrosinase inhibitory and antimelanoma activity: Prunus mahaleb L, Food Biosci., 48, 101804, 10.1016/j.fbio.2022.101804 Anwer, 2022, Preparation and evaluation of diosmin-loaded diphenylcarbonate-cross-linked cyclodextrin nanosponges for breast cancer therapy, Pharmaceuticals, 16, 19, 10.3390/ph16010019 K. Kumar, V. Rani, M. Mishra, R. Chawla, New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy, Curr. Res. Pharmacol. Drug Disc.. (2022) 100103. Sadhukhan, 2019, Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy, Mater. Sci. Eng. C, 100, 129, 10.1016/j.msec.2019.02.096 Kumari, 2021, PGMD/curcumin nanoparticles for the treatment of breast cancer, Sci. Rep., 11, 1, 10.1038/s41598-021-81701-x Kumar, 2021, Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer, J. Drug Delivery Sci. Technol., 65, 10.1016/j.jddst.2021.102677 Öztürk, 2020, Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay, Microvasc. Res., 128, 10.1016/j.mvr.2019.103961 Yang, 2019, Applying an innovative biodegradable self-assembly nanomicelles to deliver α-mangostin for improving anti-melanoma activity, Cell Death Dis., 10, 1, 10.1038/s41419-019-1323-9 H. Zeng, J. Li, K. Hou, Y. Wu, H. Chen, Z. Ning, Melanoma and nanotechnology-based treatment, Front. Oncol. (2022) 875. Iravani, 2022, Nanosponges for drug delivery and cancer therapy: recent advances, Nanomaterials, 12, 2440, 10.3390/nano12142440 Anwar, 2021, Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes, Expert Opin. Drug Deliv., 18, 1609, 10.1080/17425247.2021.1955853 Dorjay, 2018, Silymarin: an interesting modality in dermatological therapeutics, Indian J. Dermatol. Venereol. Leprol., 84 Iqbal, 2019, Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer, Nanomedicine, 14, 1077, 10.2217/nnm-2018-0235 Singh, 2016, Design of topical nanostructured lipid carrier of silymarin and its effect on 7, 12-dimethylbenz [a] anthracene (DMBA) induced cellular differentiation in mouse skin, RSC Adv., 6, 84965, 10.1039/C6RA20231D Deep, 2007, Chemopreventive efficacy of silymarin in skin and prostate cancer, Integr. Cancer Ther., 6, 130, 10.1177/1534735407301441 Kim, 2021, Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis, Oncol. Lett., 21, 1, 10.3892/ol.2021.12753 Yu, 2012, Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog, Phytother. Res., 26, 709, 10.1002/ptr.3618 Khorsandi, 2017, Silymarin induces a multi-targeted cell death process in the human colon cancer cell line HT-29, Biomed. Pharmacother., 94, 890, 10.1016/j.biopha.2017.08.015 Wu, 2016, Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells, Biomed. Pharmacother., 81, 460, 10.1016/j.biopha.2016.04.039 Singh, 2022, Box-Behnken design optimized silibinin loaded glycerylmonooleate nanoliquid crystal for brain targeting, Chem. Phys. Lipids, 244, 10.1016/j.chemphyslip.2022.105193 Singh, 2021, Formulation and optimization of silymarin-encapsulated binary micelles for enhanced amyloid disaggregation activity, Drug Dev. Ind. Pharm., 47, 1775, 10.1080/03639045.2022.2059498 Elsamaligy, 2006, Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance, Int. J. Pharm., 319, 121, 10.1016/j.ijpharm.2006.04.023 Yousaf, 2019, Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization, J. Pharm. Anal., 9, 34, 10.1016/j.jpha.2018.09.003 Adhikari, 2019, Cold atmospheric plasma and silymarin nanoemulsion synergistically inhibits human melanoma tumorigenesis via targeting HGF/c-MET downstream pathway, Cell Commun. Signal., 17, 52, 10.1186/s12964-019-0360-4 Ghosh, 2011, Preparation and evaluation of silymarin β-cyclodextrin molecular inclusion complexes, J. Young Pharm., 3, 205, 10.4103/0975-1483.83759 Tan, 2014, Characterization and in vitro sustained release of silibinin from pH responsive carbon nanotube-based drug delivery system, J. Nanomater., 2014, 1 Zare, 2021, Chitosan-functionalized Fe3O4 nanoparticles as an excellent biocompatible nanocarrier for silymarin delivery, Polym. Adv. Technol., 32, 4094, 10.1002/pat.5416 Ahmad, 2015, Silymarin: an insight to its formulation and analytical prospects, Acta Physiol. Plant., 37, 253, 10.1007/s11738-015-2008-3 Takke, 2019, Nanotherapeutic silibinin: an insight of phytomedicine in healthcare reformation, Nanomed.: Nanotechnol. Biol. Med., 21, 10.1016/j.nano.2019.102057 Palliyage, 2021, Novel curcumin-resveratrol solid nanoparticles synergistically inhibit proliferation of melanoma cells, Pharm. Res., 38, 851, 10.1007/s11095-021-03043-7 Swaminathan, 2010, Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity, Eur. J. Pharm. Biopharm., 74, 193, 10.1016/j.ejpb.2009.11.003 Argenziano, 2019, Paclitaxel-loaded nanosponges inhibit growth and angiogenesis in melanoma cell model, Front. Pharmacol., 10, 776, 10.3389/fphar.2019.00776 Pushpalatha, 2018, Cross-linked, cyclodextrin-based nanosponges for curcumin delivery-physicochemical characterization, drug release, stability and cytotoxicity, J. Drug Delivery Sci. Technol., 45, 45, 10.1016/j.jddst.2018.03.004 Argenziano, 2020, Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models, Cancers, 12, 162, 10.3390/cancers12010162 Palminteri, 2021, Cyclodextrin nanosponge for the GSH-mediated delivery of Resveratrol in human cancer cells, Nanotheranostics., 5, 197, 10.7150/ntno.53888 Kumar, 2021, Novel dithranol loaded cyclodextrin nanosponges for augmentation of solubility, photostability and cytocompatibility, Curr. Nanosci., 17, 747, 10.2174/1573413716666201215165552 Kumar, 2020, Cyclodextrin nanosponges: a promising approach for modulating drug delivery Utzeri, 2022, Cyclodextrin-based nanosponges: overview and opportunities, Front. Chem., 10, 10.3389/fchem.2022.859406 Gholibegloo, 2019, Improved curcumin loading, release, solubility and toxicity by tuning the molar ratio of cross-linker to β-cyclodextrin, Carbohydr. Polym., 213, 70, 10.1016/j.carbpol.2019.02.075 Anandam, 2014, Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects, J. Mater. Sci., 49, 8140, 10.1007/s10853-014-8523-6 Kumar, 2022, Formulation and modification of physicochemical parameters of p-Coumaric acid by cyclodextrin nanosponges, J. Incl. Phenom. Macrocycl. Chem., 1–14 Allahyari, 2021, In-vitro characterization and cytotoxicity study of flutamide loaded cyclodextrin nanosponges, J. Drug Deliv. Sci. Technol., 61 Srivastava, 2021, Formulation development, in vitro and in vivo evaluation of topical hydrogel formulation of econazole nitrate-loaded β-cyclodextrin nanosponges, J. Pharm. Sci., 110, 3702, 10.1016/j.xphs.2021.07.008 B. Gupta, P. Dalal, R. Rao, Cyclodextrin decorated nanosponges of sesamol: antioxidant, anti-tyrosinase and photostability assessment, Food Biosci. (2021) 101098. https://doi.org/10.1016/j.fbio.2021.101098. Soodvilai, 2019, Effects of silymarin-loaded amphiphilic chitosan polymeric micelles on the renal toxicity and anticancer activity of cisplatin, Pharm. Dev. Technol., 24, 927, 10.1080/10837450.2018.1556690 Kumar, 2018, Encapsulation of babchi oil in cyclodextrin-based nanosponges: physicochemical characterization, photodegradation, and in vitro cytotoxicity studies, Pharmaceutics, 10, 169, 10.3390/pharmaceutics10040169 Gunathilake, 2018, In vitro anti-inflammatory properties of selected green leafy vegetables, Biomedicines, 6, 107, 10.3390/biomedicines6040107 Tavakoli, 2018, Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model, Artif. Cells Nanomed. Biotechnol., 46, 75, 10.1080/21691401.2018.1452021 Su, 2018, Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy, Nanomedicine, 13, 1009, 10.2217/nnm-2018-0046 Iriventi, 2020, Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis, DARU J. Pharm. Sci., 28, 489, 10.1007/s40199-020-00352-x Kumar, 2020, Enhancing efficacy and safety of azelaic acid via encapsulation in cyclodextrin nanosponges: development, characterization and evaluation, Polym. Bull., 1–28 Abdullah, 2021, Preparation and characterization of silymarin-conjugated gold nanoparticles with enhanced anti-fibrotic therapeutic effects against hepatic fibrosis in rats: role of MicroRNAs as molecular targets, Biomedicines, 9, 1767, 10.3390/biomedicines9121767 Singh, 2020, Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity, Int. J. Biol. Macromol., 149, 1198, 10.1016/j.ijbiomac.2020.02.041 Jafar, 2020, Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment, Drug Dev. Ind. Pharm., 46, 1524, 10.1080/03639045.2020.1810268 Natesan, 2014, Capping of silybin with β-cyclodextrin influences its binding with bovine serum albumin: a study by fluorescence spectroscopy and molecular modeling, Bull. Kor. Chem. Soc., 35, 2114, 10.5012/bkcs.2014.35.7.2114 Suvarna, 2021, Experimental and computational insight of the supramolecular complexes of Irbesartan with β-cyclodextrin based nanosponges, J. Drug Delivery Sci. Technol., 63, 10.1016/j.jddst.2021.102494 Giri, 2021, Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation, in vitro evaluation and physicochemical characterization, Drug Dev. Ind. Pharm., 47, 319, 10.1080/03639045.2021.1879840 Yao, 2020, In vitro and in vivo evaluation of didymin cyclodextrin inclusion complexes: characterization and chemosensitization activity, Drug Deliv., 27, 54, 10.1080/10717544.2019.1704941 Song, 2021, Enhanced bioavailability and efficacy of silymarin solid dispersion in rats with acetaminophen-induced hepatotoxicity, Pharmaceutics, 13, 628, 10.3390/pharmaceutics13050628 Agrahari, 2019, Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential, Adv. Drug Deliv. Rev., 148, 146, 10.1016/j.addr.2019.02.008 Sankar, 2013, Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity, Colloids Surf. B Biointerfaces, 108, 80, 10.1016/j.colsurfb.2013.02.033 Rao, 2013, In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan, J. Incl. Phenom. Macrocycl. Chem., 77, 135, 10.1007/s10847-012-0224-7 Weng, 2020, In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method, Pharmaceutics, 12, 732, 10.3390/pharmaceutics12080732 Pontes-Quero, 2021, Amphiphilic polymeric nanoparticles encapsulating curcumin: antioxidant, anti-inflammatory and biocompatibility studies, Mater. Sci. Eng. C, 121, 10.1016/j.msec.2020.111793 Valand, 2015, Curcumin-p-sulfonatocalix [4] resorcinarene (p-SC [4] R) interaction: thermo-physico chemistry, stability and biological evaluation, RSC Adv., 5, 8739, 10.1039/C4RA12047G Ammar, 2020, Antioxidants in cancer therapy: recent trends in application of nanotechnology for enhanced delivery, Sci. Pharm., 88, 5, 10.3390/scipharm88010005 Zhao, 2021, Inflammation and tumor progression: signaling pathways and targeted intervention, Signal Transduct. Targeted Therapy, 6, 1, 10.1038/s41392-021-00658-5 Khlifi, 2013, Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L, Food Chem. Toxicol., 55, 202, 10.1016/j.fct.2013.01.004 Opie, 1962, On the relation of necrosis and inflammation to denaturation of proteins, J. Exp. Med., 115, 597, 10.1084/jem.115.3.597 Williams, 2008, West Indian Med. J., 57 Osman, 2016, In vitro xanthine oxidase and albumin denaturation inhibition assay of Barringtonia racemosa L. and total phenolic content analysis for potential anti-inflammatory use in gouty arthritis, J. Intercultural Ethnopharmacol., 5, 343, 10.5455/jice.20160731025522 Vale, 2022, Epigallocatechin-3-gallate loaded-zein nanoparticles: characterization, stability and associated antioxidant, anti-tyrosinase and sun protection properties, J. Mol. Liq., 358, 10.1016/j.molliq.2022.119107 Kim, 2019, Tyrosinase inhibitory study of flavonolignans from the seeds of Silybum marianum (Milk thistle), Bioorg. Med. Chem., 27, 2499, 10.1016/j.bmc.2019.03.013 Reuter, 2010, Oxidative stress, inflammation, and cancer: how are they linked?, Free Radic. Biol. Med., 49, 1603, 10.1016/j.freeradbiomed.2010.09.006 Chang, 2009, An updated review of tyrosinase inhibitors, Int. J. Mol. Sci., 10, 2440, 10.3390/ijms10062440 Peram, 2019, Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation, J. Liposome Res., 29, 291, 10.1080/08982104.2018.1556292 Nair, 2022, Formulation, characterization, anti-inflammatory and cytotoxicity study of sesamol-laden nanosponges, Nanomaterials, 12, 4211, 10.3390/nano12234211 Khazaei Monfared, 2023, Nisin delivery by nanosponges increases its anticancer activity against in-vivo melanoma model, J. Drug Delivery Sci. Technol., 79, 104065, 10.1016/j.jddst.2022.104065 Ahmed, 2022, Ribociclib-loaded ethylcellulose-based nanosponges: formulation, physicochemical characterization, and cytotoxic potential against breast cancer, Adsorpt. Sci. Technol., 2022, 10.1155/2022/1922263 Torne, 2013, Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery, Pharm. Dev. Technol., 18, 619, 10.3109/10837450.2011.649855